Angiotensin II receptor blocker valsartan suppresses reactive oxygen species generation in leukocytes, nuclear factor-κB, in mononuclear cells of normal subjects:: Evidence of an antiinflammatory action

被引:182
作者
Dandona, P
Kumar, V
Aljada, A
Ghanim, H
Syed, T
Hofmayer, D
Mohanty, P
Tripathy, D
Garg, R
机构
[1] SUNY Buffalo, Div Endocrinol Diabet & Metab, Buffalo, NY 14260 USA
[2] Kaleida Hlth, Buffalo, NY 14209 USA
关键词
D O I
10.1210/jc.2002-021836
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In view of the pro-oxidant and proinflammatory effects of angiotensin II, we have tested the hypothesis that valsartan, an angiotensin receptor blocker, may exert a suppressive action on reactive oxygen species (ROS) generation, nuclear factor kappaB (NF-kappaB) in mononuclear cells. Four groups of eight normal subjects were given 1) 160 mg daily of valsartan, 2) 80 mg daily of simvastatin, 3) 40 mg quinapril, or 4) no treatment. Fasting blood samples were obtained before treatment and at d 1, 8, and 14 (7 d after the cessation of the drug). After valsartan, ROS generation by polymorphonuclear cells and mononuclear cells fell significantly by more than 40% (P<0.01). NF-kappa B binding activity and the expression of total cellular p65, a protein component of NF-kappa B, fell significantly (P<0.01). The expression of inhibitor kappaB (IkappaB) increased significantly (P<0.05). Plasma C-reactive protein (CRP) concentration fell significantly (P<0.01). All indices, except IkappaB, reverted toward baseline, 7 d after the cessation of the drug. IkappaB persisted in an elevated state. Neither quinapril nor simvastatin given for 7 d produced a suppression of ROS generation, intranuclear NF-kappaB, p65, or CRP, and these two agents did not alter cellular IkappaB either. The untreated controls also did not demonstrate a change in their ROS generation or NF-kappaB binding activity or plasma CRP concentration. We conclude that valsartan at a modest dose exerts a profound and rapid ROS and inflammation-suppressive effect that may be relevant to its potential beneficial effects in atherosclerosis, diabetes, and congestive cardiac failure. In contrast, quinapril and simvastatin produced no similar effect over the period of 1 wk. Our observations may also have implications to clinical situations in which a rapid antiinflammatory effect is required.
引用
收藏
页码:4496 / 4501
页数:6
相关论文
共 30 条
[1]   Effect of statin therapy on C-reactive protein levels - The Pravastatin Inflammation/CRP Evaluation (PRINCE): A randomized trial and cohort study [J].
Albert, MA ;
Danielson, E ;
Rifai, N ;
Ridker, PM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (01) :64-70
[2]   Increased IκB expression and diminished nuclear NF-κB in human mononuclear cells following hydrocortisone injection [J].
Aljada, A ;
Ghanim, H ;
Assian, E ;
Mohanty, P ;
Hamouda, W ;
Garg, R ;
Dandona, P .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (09) :3386-3389
[3]   Nuclear factor-κB suppressive and inhibitor-κB stimulatory effects of troglitazone in obese patients with type 2 diabetes:: Evidence of an antiinflammatory action? [J].
Aljada, A ;
Garg, R ;
Ghanim, H ;
Mohanty, P ;
Hamouda, W ;
Assian, E ;
Dandona, P .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (07) :3250-3256
[4]   A RAPID MICROPREPARATION TECHNIQUE FOR EXTRACTION OF DNA-BINDING PROTEINS FROM LIMITING NUMBERS OF MAMMALIAN-CELLS [J].
ANDREWS, NC ;
FALLER, DV .
NUCLEIC ACIDS RESEARCH, 1991, 19 (09) :2499-2499
[5]   PRINCE's prospects: Statins, inflammation, and coronary risk [J].
Azar, RR ;
Waters, DD .
AMERICAN HEART JOURNAL, 2001, 141 (06) :881-883
[6]   NF-kappa B: Ten years after [J].
Baeuerle, PA ;
Baltimore, D .
CELL, 1996, 87 (01) :13-20
[7]  
BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141
[8]   The NF-kappa B and I kappa B proteins: New discoveries and insights [J].
Baldwin, AS .
ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :649-683
[9]   Mechanisms of disease - Nuclear factor-kappa b - A pivotal transcription factor in chronic inflammatory diseases [J].
Barnes, PJ ;
Larin, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (15) :1066-1071
[10]   Effects of simvastatin on C-reactive protein in mixed hyperlipidemic and hypertriglyceridemic patients [J].
Bays, HE ;
Stein, EA ;
Shah, AK ;
Maccubbin, DL ;
Mitchel, YB ;
Mercuri, M .
AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (09) :942-946